👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources.
Claim this profile →
Trust score 8/100
Accepting new patients
Dr
Dr Andrew Roberts
Haematology
English
12,171+
Patients seen
6
Years in practice
9
Publications
1
Languages spoken
About
Professor Andrew Roberts AM is a Clinical Haematologist. He is a past president of the Haematology Society of Australia and New Zealand and past Chair of the board of Cancer Council Victoria. Professor Roberts is currently a Director of the Australasian Leukaemia and Lymphoma Group and the Victorian Comprehensive Cancer Centre Alliance, and chairs the Life Saving Drug Program Expert Panel.
Professor Roberts' laboratory and clinical research pioneered the way for venetoclax, a new class of targeted anti-cancer drug, to become a routine treatment for selected leukaemias. He has received multiple awards for this work, including the Prime Minister's Prize for Innovation. Since 2020, Professor Roberts has served as Deputy Editor of Blood, the leading haematology journal. He continues to lead laboratory and clinical trials research into new treatments.
Professor Roberts studied for their PhD with Professor Donald Metcalf at the Walter and Eliza Hall Institute of Medical Research, then completed a post-doctoral fellowship with Dr David Williams in the USA before returning to the Walter and Eliza Hall Institute of Medical Research and The Royal Melbourne Hospital. Professor Roberts has been an academic leader in the clinical development of venetoclax, from concept through preclinical development and clinical trials to registration.
Professor Roberts is the incoming Editor-in-Chief of Blood, the most cited journal in haematology. His long-term research interests are the development of new treatments for haematological malignancies, focusing especially on those blood cancers that are currently incurable.
Professor Roberts' laboratory and clinical research pioneered the way for venetoclax, a new class of targeted anti-cancer drug, to become a routine treatment for selected leukaemias. He has received multiple awards for this work, including the Prime Minister's Prize for Innovation. Since 2020, Professor Roberts has served as Deputy Editor of Blood, the leading haematology journal. He continues to lead laboratory and clinical trials research into new treatments.
Professor Roberts studied for their PhD with Professor Donald Metcalf at the Walter and Eliza Hall Institute of Medical Research, then completed a post-doctoral fellowship with Dr David Williams in the USA before returning to the Walter and Eliza Hall Institute of Medical Research and The Royal Melbourne Hospital. Professor Roberts has been an academic leader in the clinical development of venetoclax, from concept through preclinical development and clinical trials to registration.
Professor Roberts is the incoming Editor-in-Chief of Blood, the most cited journal in haematology. His long-term research interests are the development of new treatments for haematological malignancies, focusing especially on those blood cancers that are currently incurable.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Andrew Roberts
Education & training
-
2010–2016 MD · Medicine and Surgery
-
2016–2020 Residency · Haematology
Career & appointments
-
2020-09–2021-08 Junior consultant
Licenses & insurance
Medical licenses
— Organización Médica Colegial de España (OMC)
Board certifications
European Board of Haematology
Malpractice insurance:
Generali Healthcare · 5,000,000 EUR coverage
· No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 2,117 |
| Annual physical exam | 99395 | 427 |
| Vaccination administration | 90471 | 2,763 |
| Minor procedure (skin) | 17110 | 2,956 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 120 min | in_clinic | 360.00 EUR |
| Minor procedure (skin) | 30 min | in_clinic | 270.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 4 · i10: 6
-
Validation of clinical scoring in Haematology
DOI: 10.4600/euroclin.2026.0 · PMID: 30431943 · cited by 5
-
Long-term follow-up of Haematology across
DOI: 10.2128/euroclin.2025.1 · PMID: 34716464 · cited by 175
Invited talks
- Practical updates in Haematology European Annual Congress (Haematology) · Vienna · 2024 · invited
- Single-centre experience in Haematology National Society Meeting · · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Haematology — · EuroClinics Patient Choice · 2025 · regional
Society memberships
- WONCA Europe — Family Doctors — Member · since 2021
- national college of family doctors — Member · since 2021
- European Union of Medical Specialists (UEMS) — Member · since 2021
Patient reviews
- Bedside Manner
- 0.05
- Knowledge
- 0.08
- Wait Time
- 3.80
- Staff Friendliness
- 0.02
- Ease Of Appointment
- 4.00
- Value For Money
- 4.10
- Would Recommend Pct
- 4
-
★ 5 verified visit
“Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”
-
★ 5 verified visit
“Took time to listen and reviewed all my previous results. I would absolutely recommend.”
-
★ 4 verified visit
“Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”
Articles by this doctor
- Patient education Patient guide to Haematology
- Awareness When should you see a haematology?
For international patients
- Coordinator
- Patient liaison · andrew.roberts.2@euroclinics.example
